ICU Medical Inc

ICU Medical Inc Stock Forecast & Price Prediction

Live ICU Medical Inc Stock (ICUI) Price
$105.19

1

Ratings

  • Buy 1
  • Hold 0
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$105.19

P/E Ratio

P/E Ratio not available for ICUI

Volume Traded Today

$205,918

Dividend

Dividends not available for ICUI

52 Week High/low

212.43/78.28

ICU Medical Inc Market Cap

$2.57B

🛑 Alert: These ten stocks could have higher potential than $ICUI 🛑

Before you buy ICUI you’ll want to see this list of ten stocks that have huge potential. Want to see if ICUI made the cut? Enter your email below

ICUI Summary

From what 1 stock analysts predict, the share price for ICU Medical Inc (ICUI) might increase by 4.57% in the next year. This is based on a 12-month average estimation for ICUI. Price targets go from $110.00 to $110.00. The majority of stock analysts believe ICUI is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

ICUI Analyst Ratings

About 1 Wall Street analysts have assigned ICUI 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect ICU Medical Inc to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ICUI. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

ICUI stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

kristen stewart
C.L. King

Buy

$110.0

initiatedcoverage

Dec 14, 2023
matthew mishan
KeyBanc

Buy

$216.0

maintained

May 9, 2023
jayson bedford
Raymond James

Hold

None

downgraded

Nov 8, 2022
john ransom
Raymond James

Buy

None

maintained

Aug 1, 2018
lawrence keusch
Raymond James

Buy

$265.0

reiterated

Mar 8, 2018
jennie tsai
Gabelli

Buy

None

maintained

Nov 13, 2017
brooks west
Piper Sandler

Hold

$123.0

reiterated

Jan 5, 2017
thomas gunderson
Piper Sandler

Buy

$129.0

maintained

Jan 14, 2016
lawrence solow
CJS Securities

Buy

$80.0

upgraded

Sep 23, 2014
james terwilliger
Northland Securities

Hold

$69.0

downgraded

May 9, 2013

ICUI Company Information

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

ICUI
ICU Medical Inc (ICUI)

When did it IPO

1992

Staff Count

14,500

Country

United States

Sector/Industry

Healthcare/Medical Instruments & Supplies

CEO

Mr. Vivek Jain

Market Cap

$2.57B

ICU Medical Inc(ICUI) Financial Data

In 2023, ICUI generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ICUI's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $2.25B
  • Operating Margin TTM 0.03%
  • Gross profit TTM $697.8M
  • Return on assets TTM 0.01%
  • Return on equity TTM -0.01%
  • Profit margin -0.0124699995%
  • Book value 86.93%
  • Market capitalisation $2.57B
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year -1.16
  • EPS next year N/A

ICU Medical Inc(ICUI) Latest News

... ...

Similar Stocks to ICU Medical Inc ICUI

🛑 Alert: These ten stocks could have higher potential than $ICUI 🛑

Before you buy ICUI you’ll want to see this list of ten stocks that have huge potential. Want to see if ICUI made the cut? Enter your email below

...

ICUI Frequently asked questions

The highest forecasted price for ICUI is $110.00 from kristen stewart at C.L. King.

The lowest forecasted price for ICUI is $110.00 from kristen stewart from C.L. King

The ICUI analyst ratings consensus are 1 buy ratings, 0 hold ratings, and 0 sell ratings.